To evaluate the efficacy and safety of nafamostat mesilate anticoagulation in patients treated with continuous renal replacement therapy (CRRT) in surgery intensive care unit (SICU) by retrospective study.
From January 2021 to March 2022, patients who were admitted to the department of anesthesia and critical care medicine, Xinhua hospital affiliated to Shanghai Jiao Tong university and treated with CRRT, with nafamostat mesilate (anticoagulation group) and no heparin dialysis regimen (no heparin group) were enrolled. The filter life, filter replacement rate and the incidence of extracorporeal circuit thrombosis were analyzed. The disseminated intravascular coagulation (DIC) index, platelet count, hemoglobin level, electrolytes, the occurrence of gastrointestinal bleeding, hematuria, cerebral hemorrhage and other bleeding conditions before and after CRRT in the anticoagulation group was compared, and pay attention to the cost of hospitalization and other economic indicators.
A total of 53 CRRT treatments were completed in 14 patients treated with nafamostat mesilate. A total of 67 CRRT treatments were completed in 19 patients with heparin-free anticoagulation regimen. The coagulation change rate of the filter and pipeline in the anticoagulation group was lower than that in the no heparin group (5.66% vs 17.91%, P<0.05), and the average use time of the filter was longer than that in the non-heparin group [(10.31±2.65) h vs (7.28±1.87) h, P<0.05]. The DIC index and platelet count before and after CRRT were not affected by nafamostat mesilate anticoagulation (P>0.05). In the anticoagulant group, hyperkalemia did not occur during CRRT, and the difference in serum potassium was statistically significant compared with that before treatment (P<0.05), while the difference in serum sodium and serum chloride was not statistically significant (P>0.05).
Nafamostat mesilate is a safe and effective anticoagulant for patients treated with CRRT in SICU.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |